EloyRomanMD

PubMed

• 13 citations
  Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria.
  Raymond S M Wong, Humphrey W H Pullon, Ismail Amine, Andrija Bogdanovic, Pascal Deschatelets, Cedric G Francois, Kalina Ignatova, Surapol Issaragrisil, Pimjai Niparuck...> ;Annals of Hematology. 2022 Sep 1
• 57 citations
  C3 inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab.
  Carlos M. de Castro, Federico Grossi, Ilene C. Weitz, Jaroslaw P. Maciejewski, Vivek R. Sharma, Eloy Roman, Robert A. Brodsky, Lisa Tan, Carl Di Casoli, Delphine El Me...> ;American Journal of Hematology. 2020 Nov 1
• 3 citations
  Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia.
  Richard J. Derman, Eloy Roman, Gioi N. Smith‐Nguyen, Maureen Achebe, Lars L. Thomsen, Michael Auerbach> ;American Journal of Hematology. 2018 Jun 1
• 59 citations
  A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
  Richard J. Derman, Eloy Roman, Manuel R. Modiano, Maureen Achebe, Lars L. Thomsen, Michael Auerbach> ;American Journal of Hematology. 2017 Feb 1
• Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.
  E. Roman, Luis E. Raez, Edgardo S. Santos> ;Expert Review of Anticancer Therapy. 2006 Sep 1
• Join now to see all